Exascale Labs Holdings Inc. Class A Common Stock (XLAB) - Total Liabilities
Based on the latest financial reports, Exascale Labs Holdings Inc. Class A Common Stock (XLAB) has total liabilities worth $29.15 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See operational self-sufficiency of Exascale Labs Holdings Inc. Class A Comm to measure how many days the company can operate on defensive assets alone.
Exascale Labs Holdings Inc. Class A Common Stock - Total Liabilities Trend (2024–2025)
This chart illustrates how Exascale Labs Holdings Inc. Class A Common Stock's total liabilities have evolved over time, based on quarterly financial data. See XLAB financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Exascale Labs Holdings Inc. Class A Common Stock Competitors by Total Liabilities
The table below lists competitors of Exascale Labs Holdings Inc. Class A Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Myomo Inc
NYSE MKT:MYO
|
USA | $27.75 Million |
|
Impact Coatings publ AB
ST:IMPC
|
Sweden | Skr37.50 Million |
|
Rockhaven Resources Ltd
V:RK
|
Canada | CA$3.60 Million |
|
GeneOne Life Science Inc
KO:011000
|
Korea | ₩80.13 Billion |
|
Daewoo Elec Co
KO:009320
|
Korea | ₩83.76 Billion |
|
Canterra Minerals Corporation
V:CTM
|
Canada | CA$1.41 Million |
|
Laird Superfood Inc
NYSE MKT:LSF
|
USA | $7.76 Million |
|
Sportshero Ltd
AU:SHO
|
Australia | AU$866.48K |
Liability Composition Analysis (2024–2025)
This chart breaks down Exascale Labs Holdings Inc. Class A Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Exascale Labs Holdings Inc. Class A Comm total assets.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.28 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 3.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Exascale Labs Holdings Inc. Class A Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Exascale Labs Holdings Inc. Class A Common Stock (2024–2025)
The table below shows the annual total liabilities of Exascale Labs Holdings Inc. Class A Common Stock from 2024 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $20.32 Million | +105.63% |
| 2024-06-30 | $9.88 Million | -- |
About Exascale Labs Holdings Inc. Class A Common Stock
Exascale Labs Holdings Inc. develops and operates AI computer infrastructure platforms. It offers graphics processing unit (GPU) cloud infrastructure, scalable GPU compute deployments, AI-ready data center solutions, system integration, GPU procurement and leasing, and full-stack orchestration. The company is based in Houston, Texas.